[1] Collins AJ,Foley RN,Chavers B,et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease &end-stage renal disease in the United States[J]. AM J Kidney Dis,2012,59(1 Suppl 1): A7,e1- 420.
[2] Stel VS, van de Luijtgaarden MW, et al.The 2008 ERA-EDTA Registry Annual Report-a précis[J]. NDT Plus. Feb 2011, 4(1): 1-13.
[3] 中国高血压防治指南修订委员会.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064.
[4] 李树青,刘晓梅,王维忠.丹参对自发性高血压大鼠肾小动脉硬化治疗作用的实验研究[J].中华中医药学刊,2006,24(2):224-225.
[5] Zuccheli P, Zuccala A. Recent data on hypertention and progressive renal disease[J]. J Hum Hypertens,1996,10(10):679- 682.
[6] 蔡广研,寇佳,陈香美.高血压肾损害诊治新认识[J].中国实用内科杂志,2013,33(3):173-175.
[7] Fliser D. Perspectives in renal disease progression: the endothelium as a treatment target in chronic kidney disease[J]. J Nephrol,2010,23(4): 369-376.
[8] Kuo H T,Shin S J,Kuo M C,et al. Effects of specific endthelin-1 recepter antagonisis on proliferation and firbonectin production of glomerular mesangial cells stimulated with angiotensin Ⅱ[J].Kaohsiung J Med Sci,2006,22(8): 371-376.
[9] Shanley PF. The pathology of chronic renal ischemia[J]. Semin Nephrol, 1996, 16(1): 21-32.
[10] Wolf G, Neilson EG. Angiotensin II as a renal growth factor[J]. J Am Soc Nephrol, 1993; 3(9): 1531-1540.
[11] 杨赶梅,夏娣文,佘江健,等.芪蛭胶囊治疗高血压肾病肾功能不全20例临床观察[J].中国中医药科技,2002,9(4):232-233.
[12] 张琪,朱建军,袁杰.保元灌肠液治疗高血压患者早期肾脏损害60例.南京中医药大学学报(自然科学版)[J].2001,17(3):189-190.
[13] 秦建国,王亚红,曹征,等.降压通脉方对高血压病肾损害大鼠尿微量白蛋白、NAG酶的调节作用[C]//第二届(第21次)中华中医药学会肾病分会学术会议论文集.2008:568-569.
[14] 秦建国,王亚红,梁晋普,等.郭维琴治疗高血压病经验[J].中医杂志,2007,48(7):586-589.
[1]王永,曾凯,赵红佳,等.健心颗粒对慢性心衰大鼠心室肌toll样受体4、肿瘤坏死因子-α蛋白表达的影响[J].环球中医药,2015,8(04):411.[doi:10.3969/j.issn.1674-1749.2015.04.007]
WANG Yong,ZENG Kai,ZHAO Hong-jia,et al.Effects of Jianxin Granule on the TLR4 and TNF-α of ventricular muscle in rats with chronic heart failure[J].,2015,8(01):411.[doi:10.3969/j.issn.1674-1749.2015.04.007]